OSTEOEDGE
LIVE

Serial Number

79313377

Owner

Orthocell Limited

Attorney

Matthew J. Stark

Filing Date

Feb 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

OSTEOEDGE Trademark

Serial Number: 79313377 • Registration: 6776869

OSTEOEDGE is a trademark filed by Orthocell Limited on February 24, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Orthocell Limited (15 trademarks)

Building 191,

Entity Type: 99

Trademark Details

Filing Date

February 24, 2021

Registration Date

July 5, 2022

Published for Opposition

April 19, 2022

Goods & Services

Stem cells for medical purposes; collagen for medical use; biodegradable implants being living cells or implantable scaffolds comprising biological materials for use in guided tissue regeneration; surgical implant materials being living cells or implantable scaffolds comprising biological materials for use in guided tissue regeneration; implantable materials being living cells or implantable scaffolds comprising biological materials for use in guided tissue regeneration; implants being living cells or implantable scaffolds comprising biological materials for use in guided tissue regeneration; surgical implants comprised of living tissues; medical therapeutic agents for tissue regeneration; medical therapeutic biological products, namely, biological cell cultures for medical purposes; medical preparations, namely, medical preparations for tissue regeneration; guided tissue regeneration materials, namely, materials for the regeneration of bone and soft tissue, namely, living tissue and nerve tissue; biological preparations for medical purposes for use in guided tissue regeneration for tissue repair; tissue-regenerative medical preparations for use in regeneration of damaged bone and soft tissue, namely, living tissue and nerve tissue; tissues for medical use being living cells; collagen based scaffolding for biomechanical support and stabilization, namely, implantable scaffolds comprising biological materials; cellular therapeutic tendon and cartilage regeneration products, namely, living cells or implantable scaffolds comprising biological materials

Advisory services relating to medical services namely providing advice in the field of bone and soft tissue regeneration; medical services; medical advisory services; medical care services for the regeneration of bone and soft tissue; medical health assessment services; medical treatment services for the regeneration of bone and soft tissue; provision of medical information; provision of medical services; therapy services for the regeneration of bone and soft tissue; physical therapy; medical services, including those relating to biomechanical and cellular therapeutic medical techniques

Medical implants, namely, implants made from artificial biomaterials, namely, synthetic collagen, for use in the regeneration of bone and soft tissue, and nerve tissue; orthopaedic implants, namely, implants made from artificial biomaterials for use in the regeneration of bone and soft tissue, and nerve tissue; surgical implants comprised of artificial materials; dental implants made of artificial materials; biodegradable bone fixation implants made of artificial materials; surgical implants comprised of artificial materials for use in guided tissue regeneration; surgical implants comprised of artificial materials for replacing human tissue; surgical prostheses, namely, implantable scaffolds comprising artificial materials for the regeneration of bone and soft tissue and nerve tissue; artificial skin for surgical purposes; surgical prosthesis implants made of artificial materials for use in human medicine; orthopaedic materials, namely, orthopaedic materials made from artificial biomaterials for use in the regeneration of bone and soft tissue, and nerve tissue; artificial orthopaedic implants; artificial materials for use in guided tissue regeneration, namely, implantable scaffolds comprising artificial biomaterials for the regeneration of bone and soft tissue, and nerve tissue; artificial replacement materials for human tissue, namely, synthetic collagen based scaffolding materials; surgical implants comprised of artificial materials for replacing animal and human tissue

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 7, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 18, 2022 FICS
FINAL DISPOSITION PROCESSED
Oct 18, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 5, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 5, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 5, 2022 R.PR
NOTIFICATION PROCESSED BY IB
May 3, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 19, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 19, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 13, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 13, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 30, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 11, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 11, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 11, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 11, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 18, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 18, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 18, 2022 TROA
REFUSAL PROCESSED BY IB
Nov 5, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 12, 2021 RFCS
REFUSAL PROCESSED BY MPU
Oct 12, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 26, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 25, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 19, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 26, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 22, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 17, 2021 REPR